NasdaqCM - Delayed Quote USD

Polyrizon Ltd. (PLRZ)

Compare
0.9356 +0.0256 (+2.81%)
At close: November 22 at 4:00 PM EST
0.9300 -0.01 (-0.60%)
After hours: November 22 at 7:56 PM EST
Loading Chart for PLRZ
DELL
  • Previous Close 0.9100
  • Open 0.9289
  • Bid 0.9205 x 200
  • Ask 0.9723 x 200
  • Day's Range 0.9001 - 1.0000
  • 52 Week Range 0.7700 - 1.9700
  • Volume 75,020
  • Avg. Volume 486,400
  • Market Cap (intraday) 3.924M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a containment barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

www.polyrizon-biotech.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PLRZ

View More

Performance Overview: PLRZ

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PLRZ
42.95%
S&P 500
2.34%

1-Year Return

PLRZ
42.95%
S&P 500
2.34%

3-Year Return

PLRZ
42.95%
S&P 500
2.34%

5-Year Return

PLRZ
42.95%
S&P 500
2.34%

Compare To: PLRZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PLRZ

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    3.92M

  • Enterprise Value

    4.05M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.07M

  • Diluted EPS (ttm)

    -0.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23k

  • Total Debt/Equity (mrq)

    68.02%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: PLRZ

View More

Company Insights: PLRZ

Research Reports: PLRZ

View More

People Also Watch